|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.780 USD | -5.03% |
|
-6.67% | -30.87% |
| 05-12 | Bolt Biotherapeutics reports first quarter 2026 financial results | RE |
| 05-12 | Bolt Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 4.36 | 5.31 | 5.25 |
| Spread/Res. | -13.30% | -28.81% | -28.00% |
| Spread/Supp. | +11.66% | +25.34% | +19.77% |
| Support | 3.385 | 3.016 | 3.156 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- BOLT Stock
- Charts Bolt Biotherapeutics, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
